L-α-Lecithin (soybean)

Name: L-α-Lecithin (soybean)
Brand: MedChemExpress
SKU: HY-B2235C
Rating: 4.5 (1 reviews)

Cat. No.: HY-B2235C: Data Sheet
COA

SDS
Handling Instructions
FAQs
Technical Support

L-α-Lecithin (soybean) is an orally active phospholipid. L-α-Lecithin (soybean) increases the bioavailability of Lutein in plasma and eyes of Rattus norvegicus, enhances plasma Glutathione peroxidase activity, and regulates fatty acids in plasma and tissues.

For research use only. We do not sell to patients.

L-α-Lecithin (soybean) Chemical Structure

CAS No. : 8002-43-5

Size	Stock	Quantity
5 g	In-stock	Estimated Time of Arrival: December 31
10 g	In-stock	Estimated Time of Arrival: December 31
25 g	In-stock	Estimated Time of Arrival: December 31
50 g	In-stock	Estimated Time of Arrival: December 31
100 g	In-stock	Estimated Time of Arrival: December 31
> 100 g	Get quote

or Bulk Inquiry

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

Other Forms of L-α-Lecithin (soybean):

Lecithin In-stock

Featured Recommendations

•Related Small Molecules:

•Related Proteins:

View All Glutathione Peroxidase Isoform Specific Products:

View All Isoforms

GPX1 GPX4

Biological Activity
Purity & Documentation
References
Customer Review

Description

In Vivo

Dietary L-α-Lecithin (soybean) (10% of the diet; p.o.; ad lib; 4 weeks) enhances lutein bioavailability in plasma and eyes by up to 31.3%, elevates plasma glutathione peroxidase activity, increases malonaldehyde levels in plasma, liver, and eyes, and alters plasma, liver, and eye lipid and fatty acid profiles in male Wistar rats^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:	Wistar rats (male, 42 ± 2 g)^[1]
Dosage:	10% of the diet
Administration:	p.o.; ad lib; 4 weeks
Result:	Increased plasma lutein levels by 20% compared to control. Increased eye lutein levels by 31.3% compared to control. Showed no significant difference in liver lutein levels compared to control. Increased plasma glutathione peroxidase activity by 21.4% compared to control. Increased plasma malonaldehyde levels by 29% compared to control. Increased liver malonaldehyde levels by 47.2% compared to control. Increased eye malonaldehyde levels by 10.1% compared to control. Significantly increased plasma, liver, and eye phospholipid levels compared to control. Significantly increased eye cholesterol levels compared to control. Achieved plasma oleic acid levels of 36.2% of total fatty acids. Achieved liver oleic acid levels of 31.3% of total fatty acids. Achieved eye oleic acid levels of 28.3% of total fatty acids.

CAS No.

8002-43-5

Appearance

Solid

Color

Light yellow to yellow

SMILES

O=P(OCC[N+](C)(C)C)([O-])OC[C@@H](COC([R])=O)OC([R'])=O.[R,R'=fatty acid residues]

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Powder	-20°C	3 years
In solvent	-80°C	6 months
	-20°C	1 month

Purity & Documentation

Select Batch:

Data Sheet (273 KB) SDS (645 KB)

COA (250 KB) HNMR (247 KB)

Handling Instructions (2659 KB)

References

[1]. Lakshminarayana R, et al. Phospholipid, oleic acid micelles and dietary olive oil influence the lutein absorption and activity of antioxidant enzymes in rats. Lipids. 2009;44(9):799-806. [Content Brief]